Skip to main content

8 Result(s)

within Yoo-Young Lee Remove this filter Oncology Remove this filter

and

  1. Article

    Efficacy of the PRO-CTCAE mobile application for improving patient participation in symptom management during cancer treatment: a randomized controlled trial

    Although mobile-based symptom monitoring is expected to improve patient participation in symptom management during anticancer therapy, previous trials have not evaluated its effectiveness. Therefore, this stud...

    Mangyeong Lee, Danbee Kang, Eunjee Kang, Sooyeon Kim… in Supportive Care in Cancer (2023)

    Download PDF (1024 KB) View Article

  2. Article

    Open Access

    Safety and efficacy study of laparoscopic or robotic radical surgery using an endoscopic stapler for inhibiting tumour spillage of cervical malignant neoplasms evaluating survival (SOLUTION): a multi-centre, open-label, single-arm, phase II trial protocol

    The Laparoscopic Approach to Cervical Cancer trial and Surveillance, Epidemiology, and End Results program database study demonstrated that minimally invasive radical hysterectomy was inferior to abdominal rad...

    Soo ** Park, Tae Wook Kong, Taehun Kim, Maria Lee, Chel Hun Choi… in BMC Cancer (2022)

    Download PDF (1093 KB) View Article

  3. Article

    The Two Faces of Adjuvant Glucocorticoid Treatment in Ovarian Cancer

    Adjuvant glucocorticoid treatment is routinely used in the treatment of ovarian cancer to mitigate the undesirable side effects of chemotherapy, thereby enhancing tolerability to higher cytotoxic drug doses an...

    Vladimir Djedovic, Yoo-Young Lee, Alexandra Kollara, Taymaa May… in Hormones and Cancer (2018)

    Download PDF (721 KB) View Article

  4. No Access

    Article

    Meta-analysis of the effects of beta blocker on survival time in cancer patients

    This study was to elucidate the potential benefit of beta blockers on cancer survival.

    Chel Hun Choi, Taejong Song, Tae Hyun Kim… in Journal of Cancer Research and Clinical On… (2014)

  5. No Access

    Article

    Safety and efficacy of aprepitant, ramosetron, and dexamethasone for chemotherapy-induced nausea and vomiting in patients with ovarian cancer treated with paclitaxel/carboplatin

    Women with ovarian carcinoma that are treated with paclitaxel/carboplatin are particularly susceptible to chemotherapy-induced nausea and vomiting (CINV). The current study evaluated the new combination (aprep...

    Chel Hun Choi, Min Kyu Kim, **-Young Park, Aera Yoon… in Supportive Care in Cancer (2014)

  6. No Access

    Article

    Phase II study of ifosfamide and cisplatin for the treatment of recurrent ovarian cancer

    The aim of this phase II study was to investigate the efficacy and toxicity of combined ifosfamide and cisplatin chemotherapy in patients with recurrent epithelial ovarian cancer (EOC).

    Taejong Song, Min Kyu Kim, Yoo-Young Lee… in Cancer Chemotherapy and Pharmacology (2013)

  7. No Access

    Article

    Overexpression of Galectin-3 and its clinical significance in ovarian carcinoma

    Galectin-3 (Gal-3) is a β-galactoside-binding lectin involved in regulating cell growth, angiogenesis, and tumor progression. We investigated the clinical significance of Gal-3 expression including its possibl...

    Min Kyu Kim, Chang Ohk Sung, In-Gu Do… in International Journal of Clinical Oncology (2011)

  8. No Access

    Article

    Direct inhibition of eIF4E reduced cell growth in endometrial adenocarcinoma

    Eukaryotic translation initiation factor 4E (eIF4E) is overexpressed in many cancer and is emerging as a potential therapeutic target. Yet data on the expression of eIF4E in endometrial cancer are lacking.

    Chel Hun Choi, Ji-Soo Lee, Seong Rim Kim… in Journal of Cancer Research and Clinical On… (2011)